Immediate Impact
51 standout
Citing Papers
Incident allergic diseases in post-COVID-19 condition: multinational cohort studies from South Korea, Japan and the UK
2024 Standout
Advances in diagnosis and treatment of bladder cancer
2024 Standout
Works of Adam Raymakers being referenced
Cost effectiveness of newly approved second/third-line agents in metastatic urothelial carcinoma (mUC).
2022
Inhaled corticosteroids and the risk of lung cancer in COPD: a population-based cohort study
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Adam Raymakers | 94 | 213 | 46 | 138 | 126 | 46 | 624 | |
| Margaret K. Pasquale | 112 | 151 | 45 | 81 | 93 | 38 | 638 | |
| Ike Iheanacho | 60 | 225 | 79 | 64 | 135 | 34 | 677 | |
| Ambica Parmar | 74 | 156 | 25 | 172 | 105 | 41 | 607 | |
| Ayesha Farooq | 69 | 194 | 49 | 291 | 77 | 43 | 706 | |
| Anne‐Marie Meyer | 63 | 150 | 45 | 180 | 107 | 41 | 639 | |
| Carlos Canelo‐Aybar | 63 | 95 | 97 | 123 | 87 | 40 | 618 | |
| Ian S. Reynolds | 68 | 103 | 38 | 247 | 108 | 51 | 672 | |
| Mugdha Gokhale | 73 | 131 | 26 | 119 | 53 | 29 | 578 | |
| Marie‐Eve Beauchamp | 74 | 74 | 58 | 65 | 91 | 28 | 727 | |
| Ilaria Ardoino | 65 | 110 | 32 | 171 | 85 | 43 | 682 |
All Works
Login with ORCID to disown or claim papers
Loading papers...